132 related articles for article (PubMed ID: 20975307)
1. How to treat multiple myeloma - a representative multicentre treatment survey.
Knauf W; Kellermann L; Poenisch W; Einsele H; Straka C; Frohn C; Goldschmidt H
Onkologie; 2010; 33(11):604-10. PubMed ID: 20975307
[TBL] [Abstract][Full Text] [Related]
2. How to treat multiple myeloma: thoughts on a multicentre survey in Germany.
Bladé J; Rosiñol L; Cibeira MT; de Larrea CF
Onkologie; 2010; 33(11):577-8. PubMed ID: 20975302
[No Abstract] [Full Text] [Related]
3. Modern treatment options for elderly patients with multiple myeloma.
Görner M; Späth-Schwalbe E;
Onkologie; 2008 Jun; 31(6):335-42. PubMed ID: 18547977
[TBL] [Abstract][Full Text] [Related]
4. Less than half of patients aged 65 years or under with myeloma proceed to transplantation: results of a two region population-based survey.
Morris TC; Velangi M; Jackson G; Marks DI; Ranaghan L; ; ;
Br J Haematol; 2005 Feb; 128(4):510-2. PubMed ID: 15686460
[TBL] [Abstract][Full Text] [Related]
5. "Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?".
Moreau P; Rajkumar SV
Leuk Res; 2012 Jun; 36(6):677-81. PubMed ID: 22430045
[No Abstract] [Full Text] [Related]
6. Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.
Alegre A; Granda A; Martínez-Chamorro C; Díaz-Mediavilla J; Martínez R; García-Laraña J; Lahuerta JJ; Sureda A; Bladé J; de la Rubia J; Fernández-Rañada JM; San Miguel J; ; ;
Haematologica; 2002 Jun; 87(6):609-14. PubMed ID: 12031917
[TBL] [Abstract][Full Text] [Related]
7. Population-based patterns of care in the first-line treatment of patients with advanced esophagogastric adenocarcinoma in Germany.
Hofheinz RD; Al-Batran SE; Ridwelski K; Görg C; Wehle K; Birth M; Fetscher S; Scheiber H; Lukan N; Lordick F
Onkologie; 2010; 33(10):512-8. PubMed ID: 20926898
[TBL] [Abstract][Full Text] [Related]
8. [Acute ST-segment-elevation myocardial infarction. Current treatment situation for patients in Germany].
Zeymer U; Gitt A; Senges J
Herz; 2005 May; 30(3):241-3. PubMed ID: 15902376
[No Abstract] [Full Text] [Related]
9. Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices.
Pajic B;
Curr Med Res Opin; 2003; 19(2):95-101. PubMed ID: 12740152
[TBL] [Abstract][Full Text] [Related]
10. [Hypothermia after cardiac arrest--daily trained clinical practice? A survey at northern Germany hospitals].
Heller G; Gräsner JT; Dörges V; Scholz J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Jun; 42(6):419-20. PubMed ID: 17607609
[TBL] [Abstract][Full Text] [Related]
11. Implementation of treatment guidelines to support judicious use of antibiotic therapy.
Deuster S; Roten I; Muehlebach S
J Clin Pharm Ther; 2010 Feb; 35(1):71-8. PubMed ID: 20175814
[TBL] [Abstract][Full Text] [Related]
12. [Guidelines for the diagnosis and management of multiple myeloma by the Japan Myeloma Study Group].
Shimizu K;
Rinsho Ketsueki; 2005 Jun; 46(6):424-32. PubMed ID: 16447724
[No Abstract] [Full Text] [Related]
13. Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients.
Patriarca F; Sperotto A; Prosdocimo S; Geromin A; Zaja F; Fanin R
Haematologica; 2003 May; 88(5):597-9. PubMed ID: 12745281
[No Abstract] [Full Text] [Related]
14. Results of the MSMS Survey on Practice Characteristics.
Lester JL
Mich Med; 1993 May; 92(5):6-50. PubMed ID: 8231935
[No Abstract] [Full Text] [Related]
15. Impact of treatment guidelines and implementation of a quality assurance program on quality of care in endometrial cancer.
du Bois A; Strutas D; Buhrmann C; Traut A; Ewald-Riegler N; Kommoss S; Gomez R; Harter P
Onkologie; 2009 Sep; 32(8-9):493-8. PubMed ID: 19745593
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.
O'Shea D; Giles C; Terpos E; Perz J; Politou M; Sana V; Naresh K; Lampert I; Samson D; Narat S; Kanfer E; Olavarria E; Apperley JF; Rahemtulla A
Bone Marrow Transplant; 2006 Apr; 37(8):731-7. PubMed ID: 16501593
[TBL] [Abstract][Full Text] [Related]
17. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
Klepin HD; Hurd DD
Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
[TBL] [Abstract][Full Text] [Related]
18. [Multiple myeloma; treatment in the year 1998].
Lokhorst HM; Sonneveld P; Wijermans PW; Segeren CM
Ned Tijdschr Geneeskd; 1998 Jul; 142(28):1596-602. PubMed ID: 9763840
[TBL] [Abstract][Full Text] [Related]
19. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003.
Kristinsson SY; Landgren O; Dickman PW; Derolf AR; Björkholm M
J Clin Oncol; 2007 May; 25(15):1993-9. PubMed ID: 17420512
[TBL] [Abstract][Full Text] [Related]
20. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
